3000+ Attendees, 450 Speakers, 12 Conference Tracks, 100+ Posters
MMTC M Header 

Cambridge Healthtech Institute’s Second Annual

Circulating Cell-Free DNA

Pushing the Limits of Early Detection

February 19-20, 2015 | The InterContinental San Francisco | San Francisco, CA


Circulating nucleic acids are an important emerging biomarker in cancer and prenatal diagnostics as well as a non-invasive diagnostic solution for a wide range of clinical disorders. Cambridge Healthtech Institute's Second Annual Circulating Cell-Free DNA will cover clinical, technical, and biological aspects of both cfDNA and cfRNA. In addition to exploring applications in cancer and prenatal diagnostics, this event will assess existing detection technologies and showcase novel approaches for rare event and minimal residual disease detection.

Who Should Attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields such as Prenatal Diagnostics, Cardiovascular Medicine, Cell Biology, Biomarker Research, Mechanical Engineering, and Molecular Biology.

Topics will include, but are not limited to: 

  • Circulating tumor DNA (ctDNA)
    o Methylation of ctDNA
    o Monitoring disease and treatment progress
    o ctDNA in clinical trials
    o Exosome profiling of tumors
  • cfDNA in maternal fetal testing
    o Testing for single-gene disorders
    o Ethical considerations
  • Other applications for circulating free DNA
    o Brain injury outcome prediction
    o Immunology and inflammation
    o Organ transplantation monitoring
    o Cardiovascular risk assessment
  • Technology to capture and characterize
    o PCR and high resolution melting
    o Digital PCR for molecular counting
    o Next-generation sequencing approaches
    o Targeted allele analysis
  • New applications for circulating RNA

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is July 18, 2014. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Samantha Lewis
Conference Director
Cambridge Healthtech Institute
T: (+1) 781-972-5461
E: slewis@healthtech.com 

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

Joseph Vacca (Companies L-Z)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com 


Premier Sponsors:

Leica Biosystems 





Jackson Laboratory - small logo